Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffi Oesterreich

Showing results (31-40 of 231) with videos related to

Pageof 24
Sort By:
Steroids|November 27, 2012
Invasive lobular carcinoma of the breast: patient response to systemic endocrine therapy and hormone response in model systemsMatthew J Sikora, Rachel C Jankowitz, David J Dabbs, et al.
Biostatistics (Oxford, England)|August 24, 2016
Integrative clustering of multi-level omics data for disease subtype discovery using sequential double regularizationSunghwan Kim, Steffi Oesterreich, Seyoung Kim, et al.
Breast Cancer Research : BCR|January 30, 2008
The role of single nucleotide polymorphisms in breast cancer metastasisJames M Rae, Todd C Skaar, Susan G Hilsenbeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2016
New Strategies in Metastatic Hormone Receptor-Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and Other Targeted TherapiesRachel C Jankowitz, Steffi Oesterreich, Adrian V Lee, et al.
Molecular and Cellular Endocrinology|August 15, 2015
The estrogen receptor alpha nuclear localization sequence is critical for fulvestrant-induced degradation of the receptorAngelo J Casa, Daniel Hochbaum, Sreeja Sreekumar, et al.
Molecular Endocrinology (Baltimore, Md.)|April 16, 2010
Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressorSudipan Karmakar, Tong Gao, Margaret C Pace, et al.
Molecular Endocrinology (Baltimore, Md.)|October 1, 2005
Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressorShiming Jiang, Rene Meyer, Kaiyan Kang, et al.
Molecular and Cellular Endocrinology|August 16, 2015
Treating gynecologic malignancies with selective estrogen receptor downregulators (SERDs): promise and challengesMichelle M Boisen, Courtney L Andersen, Sreeja Sreekumar, et al.
Endocrine-Related Cancer|October 10, 2012
Hormone response in ovarian cancer: time to reconsider as a clinical target?Francesmary Modugno, Robin Laskey, Ashlee L Smith, et al.
Breast Cancer Research and Treatment|January 13, 2009
Low SAFB levels are associated with worse outcome in breast cancer patientsStephanie Hammerich-Hille, Valerie J Bardout, Susan G Hilsenbeck, et al.
Pageof 24

Showing results (31-40 of 231) with videos related to

Sort By:
Pageof 24
Steroids|November 27, 2012
Invasive lobular carcinoma of the breast: patient response to systemic endocrine therapy and hormone response in model systemsMatthew J Sikora, Rachel C Jankowitz, David J Dabbs, et al.
Biostatistics (Oxford, England)|August 24, 2016
Integrative clustering of multi-level omics data for disease subtype discovery using sequential double regularizationSunghwan Kim, Steffi Oesterreich, Seyoung Kim, et al.
Breast Cancer Research : BCR|January 30, 2008
The role of single nucleotide polymorphisms in breast cancer metastasisJames M Rae, Todd C Skaar, Susan G Hilsenbeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2016
New Strategies in Metastatic Hormone Receptor-Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and Other Targeted TherapiesRachel C Jankowitz, Steffi Oesterreich, Adrian V Lee, et al.
Molecular and Cellular Endocrinology|August 15, 2015
The estrogen receptor alpha nuclear localization sequence is critical for fulvestrant-induced degradation of the receptorAngelo J Casa, Daniel Hochbaum, Sreeja Sreekumar, et al.
Molecular Endocrinology (Baltimore, Md.)|April 16, 2010
Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressorSudipan Karmakar, Tong Gao, Margaret C Pace, et al.
Molecular Endocrinology (Baltimore, Md.)|October 1, 2005
Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressorShiming Jiang, Rene Meyer, Kaiyan Kang, et al.
Molecular and Cellular Endocrinology|August 16, 2015
Treating gynecologic malignancies with selective estrogen receptor downregulators (SERDs): promise and challengesMichelle M Boisen, Courtney L Andersen, Sreeja Sreekumar, et al.
Endocrine-Related Cancer|October 10, 2012
Hormone response in ovarian cancer: time to reconsider as a clinical target?Francesmary Modugno, Robin Laskey, Ashlee L Smith, et al.
Breast Cancer Research and Treatment|January 13, 2009
Low SAFB levels are associated with worse outcome in breast cancer patientsStephanie Hammerich-Hille, Valerie J Bardout, Susan G Hilsenbeck, et al.
Pageof 24